Cirrhotics with variceal hemorrhage: the importance of the time interval between admission and the start of analysis for survival and rebleeding rates
- PMID: 2785478
- DOI: 10.1002/hep.1840090602
Cirrhotics with variceal hemorrhage: the importance of the time interval between admission and the start of analysis for survival and rebleeding rates
Abstract
The importance of variable time of entry for analysis of survival following variceal bleeding has recently been disputed. In a study of 194 cirrhotic patients with bleeding esophageal varices in whom 2-day mortality was 3%, statistically significant differences in both survival and rebleeding rates were obtained by shifting the starting point for analysis of survival by 2 weeks following admission to hospital or by 5 days for the analysis of rebleeding. In addition, the curve of hazard function for death or for failure to control bleeding following admission clearly showed that any change in entry time in a study of variceal bleeding would introduce bias and alter survival or rebleeding rates. Thus, the starting point for analysis following variceal hemorrhage is an important confounding variable when calculating both survival and rebleeding. It should always be taken into account, particularly in clinical trials, which are often performed in centers where patients are referred from other hospitals at different times following bleeding.
Similar articles
-
Independent factors associated with recurrent bleeding in cirrhotic patients with esophageal variceal hemorrhage.Dig Dis Sci. 2009 May;54(5):1128-34. doi: 10.1007/s10620-008-0454-0. Epub 2008 Dec 3. Dig Dis Sci. 2009. PMID: 19051032
-
Independent factors associated with early outcome in Chinese cirrhotic patients after cessation of initial esophageal variceal hemorrhage.J Clin Gastroenterol. 2010 Jul;44(6):e123-7. doi: 10.1097/MCG.0b013e3181c3fb22. J Clin Gastroenterol. 2010. PMID: 20048682
-
Prognostic factors associated with rebleeding in cirrhotic inpatients complicated with esophageal variceal bleeding.Chin Med J (Engl). 2011 May;124(10):1493-7. Chin Med J (Engl). 2011. PMID: 21740804
-
Prevention of variceal rebleeding.Gastroenterol Clin North Am. 1992 Mar;21(1):119-47. Gastroenterol Clin North Am. 1992. PMID: 1349003 Review.
-
Evaluation and management of variceal bleeding.Dis Mon. 2018 Jul;64(7):312-320. doi: 10.1016/j.disamonth.2018.02.001. Epub 2018 Mar 7. Dis Mon. 2018. PMID: 29525376 Review.
Cited by
-
Factors related to early mortality in cirrhotic patients bleeding from varices and treated by urgent sclerotherapy.Gut. 1992 Oct;33(10):1381-5. doi: 10.1136/gut.33.10.1381. Gut. 1992. PMID: 1446864 Free PMC article.
-
Clinical Management of Chronic Portal/Mesenteric Vein Thrombosis: The Surgeon's Point of View.Viszeralmedizin. 2014 Dec;30(6):409-15. doi: 10.1159/000369575. Viszeralmedizin. 2014. PMID: 26288608 Free PMC article. Review.
-
Risk factors for early rebleeding and mortality in acute variceal hemorrhage.World J Gastroenterol. 2014 Dec 21;20(47):17941-8. doi: 10.3748/wjg.v20.i47.17941. World J Gastroenterol. 2014. PMID: 25548492 Free PMC article.
-
Acute management of bleeding oesophageal varices.Drugs. 1992;44 Suppl 2:14-23; discussion 70-2. doi: 10.2165/00003495-199200442-00004. Drugs. 1992. PMID: 1385067 Review.
-
Emergency portacaval shunt versus rescue portacaval shunt in a randomized controlled trial of emergency treatment of acutely bleeding esophageal varices in cirrhosis--part 3.J Gastrointest Surg. 2010 Nov;14(11):1782-95. doi: 10.1007/s11605-010-1279-7. Epub 2010 Jul 24. J Gastrointest Surg. 2010. PMID: 20658205 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical